6 hours ago
34
Tiger Global Management just wrote a $663 million check for Cerebras Systems, the AI chip startup that builds processors the size of dinner plates. The investment, disclosed in the firm’s Q2 2026 13F filing on August 14, makes Cerebras the 12th-largest holding in Chase Coleman’s portfolio.
What makes this interesting isn’t just the size of the bet. It’s what Coleman sold to fund it. The billionaire trimmed his Nvidia position in the same quarter, a move that reads less like portfolio rebalancing and more like a declaration of where he thinks the AI hardware race is headed.
The deal in context
Tiger Global picked up roughly 3 million shares of Cerebras at an average cost that works out to around $221 per share. But this isn’t Coleman’s first date with the company.
Back in February 2026, Tiger Global led Cerebras’ $1 billion Series H funding round, which valued the chipmaker at $23 billion post-money. Other investors in that round included Benchmark, Fidelity, and AMD.
A Schedule 13G filed in May 2026 revealed the full scope of Coleman’s conviction. Tiger Global entities and Charles P. Coleman III collectively held 3.496 million shares, representing 9.99% of Cerebras’ Class A common stock. That figure includes shares acquired through earlier private investments that converted when Cerebras went public.
The 9.99% threshold is worth noting. Crossing 10% triggers additional SEC reporting requirements and short-swing profit rules. Parking right below that line is a time-honored move by institutional investors who want maximum exposure with minimum regulatory friction.
Why Cerebras matters
Cerebras, headquartered in Sunnyvale, California, has built its reputation on a genuinely unusual approach to chip design. Instead of cutting a silicon wafer into hundreds of individual chips, Cerebras uses the entire wafer as a single processor. The result is a chip roughly 56 times larger than Nvidia’s biggest GPU.
The company counts OpenAI and Amazon Web Services among its reported customers. Cerebras went public shortly before the May 2026 13G filing, and the $23 billion valuation from its Series H round positioned it as one of the most valuable AI hardware companies outside of the established semiconductor giants.
Coleman’s AI chip reshuffle
The more revealing signal here is Coleman’s portfolio rotation. Reducing Nvidia exposure while simultaneously building positions in both Cerebras and Intel suggests a thesis that the AI chip market is entering a new phase.
Intel, the other beneficiary of Coleman’s capital reallocation, has been aggressively retooling its chip foundry business and pushing into AI accelerators. Where Cerebras represents a pure-play on next-generation AI hardware, Intel is a legacy turnaround story with massive manufacturing infrastructure.
One risk worth watching: Cerebras’ wafer-scale approach requires highly specialized manufacturing, and the company relies on TSMC for fabrication. Any disruption to that supply chain, whether from geopolitical tension or capacity constraints, would hit Cerebras disproportionately hard compared to chipmakers with more diversified production.
The competitive landscape is also intensifying. Google’s TPUs, AMD’s Instinct accelerators, and a growing roster of AI chip startups are all vying for the same pool of hyperscaler and enterprise spending.
Disclosure: This article was edited by Editorial Team. For more information on how we create and review content, see our Editorial Policy.
English (US) ·